Sarcopenia After COVID-19 Infection and Rehabilitation in Former Homeless Older Adults Residing in Supportive Housing: A Case Study Research

Authors

  • Phatcharaphon Whaikid Faculty of Nursing, Huachiew Chalermprakiet University, Samut Prakan, Thailand
  • Sukanya Tantiprasoplap Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
  • Anita Souza University of Washington School of Nursing, Seattle, USA
  • Jirapa Tantipongsirikul Home for the Destitute Nonthaburi, Thailand

DOI:

https://doi.org/10.60099/jtnmc.v41i02.279487

Keywords:

sarcopenia, post-COVID-19, former homeless, older adults, supportive housing

Abstract

Introduction Sarcopenia is a multifactorial geriatric syndrome characterized by progressive loss of skeletal muscle mass, muscle strength, and physical performance, leading to functional decline and increased mortality among older adults. Major contributing factors include malnutrition, chronic inflammation, comorbidities, and physical inactivity. Coronavirus disease 2019 (COVID-19) infection induces a severe inflammatory and catabolic state that accelerates muscle protein breakdown, particularly in older adults with limited physiological reserve. During the post-acute phase, prolonged immobilization, fatigue, reduced physical activity, and inadequate nutritional intake further increase the risk of sarcopenia. Older adults with a history of homelessness are particularly vulnerable due to long-standing nutritional deficits, multimorbidity, and social disadvantage. Although supportive housing provides a structured care environment, evidence regarding post-COVID-19 sarcopenia and recovery among former homeless older adults remains limited.

Objective This study aimed to describe the progression of sarcopenia following COVID-19 infection and the rehabilitation in former homeless older adults residing in supportive housing, with an emphasis on nursing assessment, rehabilitation care, and functional outcomes.

Design This study employed a descriptive case study design.

Methodology The participants were two cases: an 84-year-old former homeless man who had resided in a supportive housing facility for 13 years and a 62-year-old former homeless man who had resided in the same supportive housing facility for 7 years, who were purposively selected for comparison based on similar exposure to COVID-19 infection and comparable baseline risk of sarcopenia. Following recovery from COVID-19 infection, post-infection screening was conducted as part of routine health monitoring. Sarcopenia risk and status were assessed using standardized screening and diagnostic criteria recommended by the Asian Working Group for Sarcopenia 2019. Nursing assessment focused on muscle strength, and physical performance. A multidisciplinary rehabilitation program was implemented, coordinated by nurse researchers in collaboration with supportive housing personnel. The program included individualized resistance exercise, balance and gait training, and mobility exercises performed three times per week. Nutritional management emphasized adequate energy intake and protein supplementation, with a recommended protein intake of 1.2 g/kg body weight/day. Ongoing nursing monitoring supported adherence, safety, and continuity of care throughout the rehabilitation period. Case 1 participated in the rehabilitation program, while Case 2 did not engage in the program and maintained usual daily activities. Clinical indicators were monitored 4 points of time in both cases (T1: 3 months post-COVID-19, T2: 1-year follow-up, T3: pre-rehabilitation baseline conducted 6 months after T2, and T4: post-rehabilitation assessment. A cross-case analysis was conducted to examine similarities and differences in sarcopenia progression and functional outcomes.

Results Across the 4 time points, Case 1 had calf circumference of 26.5, 23.5, 25.5, and 27.0 cm, respectively; handgrip strength of 15.5, 10.85, 11.3, and 19.5 kg, respectively; physical performance score of 17.4, 20.91, 12.00, 10.71, respectively. Appendicular skeletal muscle mass index (ASMI) at T1 and T4 was 6.74 and 7.56 kg/m2, respectively. In Case 2, calf circumference was 28.5, 28.0, 28.5, 28.0 cm, respectively; handgrip strength was 16.0, 17.5, 16.0, 10.5 kg, respectively; physical performance score was 19.08, 22.33, 20.55, 27.95, respectively. ASMI at T1 and T4 was 6.30 and 5.55 kg/m2, respectively.

Recommendation This case study highlights the importance of early nursing-led screening for sarcopenia following COVID-19 infection, particularly among vulnerable older adults. Supportive housing can serve as an effective setting for post-COVID-19 rehabilitation when structured exercise, nutritional support, and multidisciplinary collaboration are integrated into routine care. Nursing practice should emphasize early identification, individualized rehabilitation planning, and continuous functional assessment to promote recovery and prevent further functional decline. Further research is recommended to examine post-COVID-19 sarcopenia management strategies in supportive housing.

Downloads

Download data is not yet available.

References

Chauhan V, Pandey A, Rakshit A, Mahajan G, Kanwar SS, Dhiman VK, et al. Musculoskeletal and neuromuscular dysfunction due to COVID-19 infection: a review. Vacunas. 2024;25(3):355–366. https://doi.org/10.1016/j.vacun.2023.09.004

Nistor-Cseppento CD, Moga TD, Bungau AF, Tit DM, Negrut N, Pasca B, et al. The Contribution of Diet Therapy and Probiotics in the Treatment of Sarcopenia Induced by Prolonged Immobilization Caused by the COVID-19 Pandemic. Nutrients. 2022;14(21):4701. https://doi.org/10.3390/nu14214701. PMID: 36364963

Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75(7):1564-1581. https://doi.org/10.1111/all.14364. PMID: 32396996

Silva DMS, Valadão TA, Caporosi C, Aguilar- Nascimento JE, Dock-Nascimento DB. Risk Factors Associated with Acute Sarcopenia in Patients Hospitalized with COVID-19. J Nutr Metab. 2024;2024:7857489. https://doi.org/10.1155/2024/7857489. PMID: 38504833

Piotrowicz K, Gąsowski J, Michel JP, Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10): 2887-98. https://doi.org/10.1007/s40520-021-01942-8. PMID: 34328636

Marusic U, Narici M, Simunic B, Pisot R, Ritzmann R. Nonuniform loss of muscle strength and atrophy during bed rest: a systematic review. J Appl Physiol (1985). 2021;131(1):194-206. https://doi.org/10.1152/japplphysiol.00363.2020. PMID: 33703945

Mayer KP, Thompson Bastin ML, Montgomery-Yates AA, Pastva AM, Dupont-Versteegden EE, Parry SM, et al. Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness. Crit Care. 2020;24(1): 637. https://doi.org/10.1186/s13054-020-03355-x. PMID: 33148301

Gérard M, Mahmutovic M, Malgras A, Michot N, Scheyer N, Jaussaud R, et al. Long-Term Evolution of Malnutrition and Loss of Muscle Strength after COVID-19: A Major and Neglected Component of Long COVID-19. Nutrients. 2021;13(11):3964. https://doi.org/10.3390/nu13113964. PMID: 34836219

Morley JE, Kalantar-Zadeh K, Anker SD. COVID-19: a major cause of cachexia and sarcopenia? J Cachexia Sarcopenia Muscle. 2020; 11(4):863-865. https://doi.org/10.1002/jcsm.12589. PMID: 32519505

Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636-2646. https://doi.org/10.1016/S0140-6736(19)31138-9. PMID: 31171417.

Zhou H, Ding X, Luo M. The association between sarcopenia and functional disability in older adults. J Nutr Health Aging. 2024;28(1):100016. https://doi.org/10.1016/j.jnha.2023.100016. PMID: 38267154.

Beaudart C, Demonceau C, Reginster JY, Locquet M, Cesari M, Cruz Jentoft AJ, et al. Sarcopenia and health-related quality of life: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(3):1228-1243. https://doi.org/10.1016/j.jnha.2023.100016. PMID: 38267154.

Kwon YE, Lee JS, Kim JY, Baeg SI, Choi HM, Kim HB, et al. Impact of sarcopenia and phase angle on mortality of the very elderly. J Cachexia Sarcopenia Muscle. 2023;14(1):279-287. https://doi.org/10.1002/jcsm.13128. PMID: 36394098

Kiernan S, Mockler D, Ní Cheallaigh C, Broderick J. Physical functioning limitations and physical activity of people experiencing homelessness: A scoping review. HRB Open Res. 2021;3:14. https://doi.org/10.12688/hrbopenres.13011.2. PMID: 33728397

Ayano G, Belete A, Duko B, Tsegay L, Dachew BA. Systematic review and meta-analysis of the prevalence of depressive symptoms, dysthymia and major depressive disorders among homeless people. BMJ Open. 2021;11(2):e040061. https://doi.org/10.1136/bmjopen-2020-040061. PMID: 33622940

Barry R, Anderson J, Tran L, Bahji A, Dimitropoulos G, Ghosh SM, et al. Prevalence of mental health disorders among individuals experiencing homelessness: A Systematic Review and Meta- Analysis. JAMA Psychiatry. 2024;81(7):691-699. https://doi.org/10.1001/jamapsychiatry.2024.0426. PMID: 38630486

Buckinx F, Reginster JY, Brunois T, Lenaerts C, Beaudart C, Croisier JL, et al. Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: results of the SENIOR cohort. J Musculoskelet Neuronal Interact. 2017;17(3):209-217. PMID: 28860423.

Rodríguez-Rejón AI, Ruiz-López MD, Wanden-Berghe C, Artacho R. Prevalence and diagnosis of sarcopenia in residential facilities: A Systematic Review. Adv Nutr. 2019;10(1):51-58. https://doi.org/10.1093/advances/nmy058. PMID: 30668619.

Xu Y, Xu JW, Wu Y, Rong LJ, Ye L, Franco OH, et al. Prevalence and prognosis of sarcopenia in acute COVID-19 and long COVID: a systematic review and meta-analysis. Ann Med. 2025;57(1):2519678. https://doi.org/10.1080/07853890.2025.2519678. PMID: 40552782.

Whaikid P, Piaseu N, Tantiprasoplap S, Krongthaeo S, Srisuk W, Jitwiriyatham T, Tantipongsirikul J, Subtema C. Prevalence and associated factors of sarcopenia risk and possible sarcopenia among older homeless adults in a home for destitute, Thailand: A cross-sectional study. Belitung Nurs J. 2025;11(6):714-721. https://doi.org/10.33546/bnj.4166. PMID: 41312034.

Rolland Y, Fielding R, Landi F, Vellas B. Implementing clinical operationalization of sarcopenia: the contribution of WHO ICOPE program. J Nutr Health Aging. 2024 Jun;28(6): 100257. https://doi.org/10.1016/j.jnha.2024.100257. PMID: 38714090

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2. https://doi.org/10.1016/j.jamda.2019.12.012. PMID: 32033882.

Yin RK. Case study research and applications: design and methods. 6th ed. Thousand Oaks (CA): Sage Publications; 2018.

Tosato M, Calvani R, Ciciarello F, Galluzzo V, Martone AM, Zazzara MB, et al. Malnutrition in COVID-19 survivors: prevalence and risk factors. Aging Clin Exp Res. 2023;35(10):2257-2265. https://doi.org/10.1007/s40520-023-02526-4. PMID: 37665556

Piotrowicz K, Gąsowski J, Michel JP, Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33(10): 2887-2898. https://doi.org/10.1007/s40520-021-01942-8.2021. PMID: 34328636.

Xu Y, Xu JW, Wu Y, Rong LJ, Ye L, Franco OH, et al. Prevalence and prognosis of sarcopenia in acute COVID-19 and long COVID: a systematic review and meta-analysis. Ann Med. 2025 Dec; 57(1):2519678. https://doi.org/10.1080/07853890.2025.2519678.2025. PMID: 40552782.

Whaikid P, Piaseu N. The effectiveness of protein supplementation combined with resistance exercise programs among community-dwelling older adults with sarcopenia: a systematic review and meta-analysis. Epidemiol Health. 2024;46:e2024030. https://doi.org/10.4178/epih.e2024030. PMID: 38374703.

Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab. 2006;291(2):E381-7. https://doi.org/10.1152/ajpendo.00488.2005. PMID: 16507602.

Orea-Tejeda A, Robles-Hernández R, González-Islas D, Jimenez-Gallardo L, Gochicoa-Rangel L, et al. Dynapenia and Sarcopenia in Post-COVID-19 Syndrome Hospitalized Patients Are Associated with Severe Reduction in Pulmonary Function. J Clin Med. 2023;12(20):6466. https://doi.org/10.3390/jcm12206466. PMID: 37892604

Martone AM, Tosato M, Ciciarello F, Galluzzo V, Zazzara MB, Pais C, et al. Sarcopenia as potential biological substrate of long COVID-19 syndrome: prevalence, clinical features, and risk factors. J Cachexia Sarcopenia Muscle. 2022 Aug;13(4): 1974-1982. https://doi.org/10.1002/jcsm.12931. PMID: 35698920

Downloads

Published

2026-04-10

How to Cite

1.
Whaikid P, Tantiprasoplap S, Souza A, Tantipongsirikul J. Sarcopenia After COVID-19 Infection and Rehabilitation in Former Homeless Older Adults Residing in Supportive Housing: A Case Study Research. J Thai Nurse Midwife Counc [internet]. 2026 Apr. 10 [cited 2026 Apr. 18];41(02):332-51. available from: https://he02.tci-thaijo.org/index.php/TJONC/article/view/279487

Issue

Section

Research Articles